MedPath

Comparison of the effects of intravenous ketamine and intravenous tramadol in the prevalence of shivering after spinal anesthesia

Phase 3
Conditions
Post Anesthesia Shivering.
Other complications of anesthesia
T88.5
Registration Number
IRCT20231021059799N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
90
Inclusion Criteria

Age group: 18 to 70 years old
Physical status according to ASA classification classes I, II, and III

Exclusion Criteria

Patients with contraindications to spinal anesthesia and presence of infection at the site of spinal anesthesia injection,
Lack of personal consent,
Obesity with BMI > 38 kg/m2,
Uncontrolled type 1 and 2 diabetes mellitus,
Uncontrolled hypertension history,
Moderate to severe valvular heart diseases,
Neurological and psychiatric disorders such as stroke, history of brain lesions, obsessive-compulsive disorder, and schizophrenia,
Fever exceeding 37.5 degrees Celsius at the beginning of the surgery,
Patients with sensitivity to ketamine and its derivatives,
Patients with sensitivity to tramadol and its derivatives,
History of alcohol consumption, drug abuse, or misuse of sedatives-hypnotics and glucocorticosteroids,
Presence of fungal and viral infections,
Excessive bleeding,
Receipt of blood products,
Prolonged surgery duration exceeding three hours,
History of recurrent nausea and vomiting following previous urological surgeries,
Patients whose operating room drapes become wet during surgery.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Shivering after spinal anesthesia in urological surgeries. Timepoint: The severity of patient's shivering will be recorded in the questionnaire every two hours post-operation and at any moment tremor symptoms occur in the patient. Method of measurement: The valid criterion for the grading of shivering is based on the 5-point scoring system of Crossley Mahajan.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath